Skip to main content

Session Coverage

March 09, 2020
Vascular Disease Management  spoke with Daniel Clair, MD, Chairman of the Department of Surgery for the Palmetto Health-USC Medical Group in Columbia, South Carolina. Dr Clair discussed the impact of new technologies for aortic aneurysm therapy on…
March 04, 2020
At an International Symposium on Endovascular Therapy (ISET) talk on choosing between fenestrated endografting (FEVAR) and standard endovascular aneurysm repair (EVAR) with adjuncts, Benjamin Starnes, MD, Chief of Vascular Surgery at University of…
March 04, 2020
Acute type A aortic dissection is a “total catastrophe in all segments” said Joseph Bavaria, MD, Director of the Thoracic Aortic Surgery Program at the University of Pennsylvania.
January 24, 2020
Joseph Lombardi, MD, described the results of a systematic review addressing whether thoracic endovascular aortic repair (TEVAR) prevents aortic growth. He also reviewed the STABLE I and STABLE II trials that compared TEVAR alone versus TEVAR and…
January 24, 2020
The Gore Ascending Aortic Stent Graft (ASG) is being tested in an early feasibility trial, offering new hope for using thoracic endovascular aortic repair (TEVAR) to treat Type A aortic dissections.
January 21, 2020
Vascular Disease Management spoke with Daniel Clair, MD, about challenges in treating aortic occlusive disease, upcoming clinical trials, and a case-based discussion at ISET.
November 20, 2019
Researchers report one of the first successful cases of a hybrid surgical and interventional approach to treat middle aortic syndrome in a 22-month-old infant, using re-expandable stents to avoid the need for further interventions.
February 07, 2018
Live cases from Miami Cardiac and Vascular Institute continued to be highlighted as ISET attendees observed interventionalists address two different patient conditions and perform case-applicable therapies.
February 06, 2018
Current advances in endovascular aneurysm repair (EVAR) were the subject of a panel discussion that also looked back at its inception 25 years ago, before it became the standard for treating aortic aneurysms.
February 06, 2018
A targeted panel discussion offered strategies for the identification and treatment of aortic syndromes and false lumen management.
Back to Top